Filtered By:
Specialty: Consumer Health News
Drug: Activase
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 17 results found since Jan 2013.
Stroke survivors lose a month of healthy life for every 15 minute delay
New research published in the journal Stroke, from the American Heart Association, found that reducing delays by just a few minutes could lead to big gains
Source: Telegraph Health - March 14, 2014 Category: Consumer Health News Tags: stroke survivors hospital ischaemic stroke alteplase Source Type: news
Gender gap in stroke treatment likely due to delay by women seeking care
Women with clot-caused strokes are less likely than men to arrive at the hospital in time to receive the best treatment, according to a European study reported in the American Heart Association journal Stroke. In the study, 11 percent of women with acute ischemic strokes were treated with the clot-dissolving medication alteplase, compared with 14 percent of men. Study participants included 5,515 patients at 12 hospitals in the Netherlands...
Source: Health News from Medical News Today - July 29, 2013 Category: Consumer Health News Tags: Stroke Source Type: news
ENCHANTED results challenge reduced alteplase dose in Asian stroke patients
A reduced dose of alteplase has failed to prove itself noninferior to the standard dose in a predominantly Asian population of patients with ischaemic stroke.
Source: MedWire News - May 10, 2016 Category: Consumer Health News Tags: Stroke Source Type: news
Alteplase confers long-term survival benefit after stroke
Alteplase treatment in patients with acute ischaemic stroke is associated with a survival benefit among those who survive the acute phase, shows further analysis of IST-3.
Source: MedWire News - July 26, 2016 Category: Consumer Health News Tags: Stroke Source Type: news
Lori’s Stroke Required Help From Doctors An Hour Away. Telemedicine Provided It.
Editor’s note: Our previous stories this American Stroke Month featured warning signs heeded and missed. Today we shift gears to showcase a textbook response to a stroke, including the crucial role of telestroke, a way for experts at another facility to help care for a patient via a webcam-type connection. The CHRONIC Care Act, which includes a provision to require Medicare to cover telestroke, will be discussed Tuesday during a hearing of the Senate Finance Committee.
Lori Hoopingarner savored her occasional weekend getaway.
Between running her financial advising company, raising a 10-year-old daughter and 6-year-old s...
Source: Healthy Living - The Huffington Post - May 15, 2017 Category: Consumer Health News Source Type: news
Alteplase Shows Lasting Benefit in Stroke SurvivorsAlteplase Shows Lasting Benefit in Stroke Survivors
Thrombolysis with alteplase has long-term benefits after stroke, although longer survival isn't among them. Reuters Health Information
Source: Medscape Medical News Headlines - July 5, 2013 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news
Stroke drug could be more widely used to clear brain blood clots
Brooks HaysEDINBURGH, Scotland, April 9 (UPI) -- New study suggests the drug alteplase is beneficial and safe for clearing blood clots in most stroke patients' brains without increased risk of bleeding.
Source: Health News - UPI.com - April 9, 2015 Category: Consumer Health News Source Type: news
Clot-busting drug improves survival for deadly form of stroke
Stephen FellerLOS ANGELES, Feb. 18 (UPI) -- Clot-busting drug Alteplase, used for heart attacks and non-bleeding strokes, can reduce disability and mortality in patients with a type of bleeding stroke.
Source: Health News - UPI.com - February 18, 2016 Category: Consumer Health News Source Type: news
Reducing doses of common stroke drug 'could save thousands of lives'
Reducing the dose of alteplase – taken by one in nine stroke patients – would slash brain bleeds by two thirds and death rates by a sixth, according to an international study led by Leicester University.
Source: the Mail online | Health - May 11, 2016 Category: Consumer Health News Source Type: news
NOR-TEST: Tenecteplase Similar to Alteplase in Stroke NOR-TEST: Tenecteplase Similar to Alteplase in Stroke
The newer thrombolytic given as a bolus dose showed functional and safety outcomes similar to those of alteplase infusion in the NOR-TEST trial.Medscape Medical News
Source: Medscape Medical News Headlines - May 19, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news
Tenecteplase Superior to Alteplase for Stroke Thrombolysis Tenecteplase Superior to Alteplase for Stroke Thrombolysis
A noninferiority study shows the successful reperfusion rate was doubled in patients scheduled for thrombectomy who received tenecteplase compared with the current standard, alteplase.Medscape Medical News
Source: Medscape Medical News Headlines - January 26, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news
I.V. Thrombolysis With Tenecteplase in Patients With LVO I.V. Thrombolysis With Tenecteplase in Patients With LVO
Is intravenous thrombolysis with tenecteplase an effective alternative to alteplase for acute ischemic stroke in patients with large vessel occlusions?Stroke
Source: Medscape Today Headlines - February 3, 2021 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news
Tenecteplase Versus Alteplase in Routine Clinical Practice Tenecteplase Versus Alteplase in Routine Clinical Practice
This paper details the results of a hospital network ' s transition from alteplase to tenecteplase as the standard of care for stroke thrombolysis. How did costs and clinical outcomes compare?Stroke
Source: Medscape Today Headlines - December 29, 2022 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news
Experts to review stroke clot-buster
The UK medicines watchdog is setting up a review to look at the safety of alteplase, a clot-busting drug often used to treat strokes.
Source: BBC News | Health | UK Edition - August 22, 2014 Category: Consumer Health News Source Type: news
VIDEO: Stroke clot drug in safety review
The UK medicines watchdog, the Medicines and Healthcare Products Regulatory Agency, is to review the safety of clot-busting drug alteplase often used to treat strokes.
Source: BBC News | Health | UK Edition - August 23, 2014 Category: Consumer Health News Source Type: news
